Rapasim contains Sirolimus is used to prevent rejection in organ transplant recipients. It prevents rejection by inhibiting the cells in the immune system that cause rejection. Rapasim may be the only immunosuppressant that is prescribed for you, or it may be prescribed to be taken with prednisone, tacrolimus or cyclosporine. Rapasim is available in 1 mg tablets. Sirolimus is a carbocyclic lactone-lactam macrolide antibiotic prepared through natural fermentation from the soil actinomycete Streptomyces hygroscopicus. It was discovered about 25 years ago in Easter Island. Over the last two decades, rapamycin has evolved as the inhibitor of the mammalian target of rapamycin (mTOR) enzyme.

Product Active Ingredient(s) Strength Features Dosage Form
RAPASIM Rapamycin/Sirolimus 1 mg • Promising alternative for the maintenance immunosuppression after renal transplantation
• Lower nephrotoxicity, less hypertension and less neoplastic potential than the calcineurin inhibitors
  • RAPASIM is indicated for the prophylaxis of organ rejection in patients receiving renal transplant
  • It is recommended that RAPASIM be used initailly in a regimen with cyclosporine and corticosteroids
  • CAN is a major indication of RAPASIM in renal transplant to prevent deterioration of renal function


Copyright © 2013 - Alniche Life Sciences Pvt. Ltd. | All Rights Reserved

Disclaimer: The information provided herein is not medical advice and is not intended to replace medical advice offered by a health care provider. Please consult your health care provider for advice.